phendimetrazine tartrate 35 MG Oral Tablet

INDICATIONS AND USAGE: Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. Phendimetrazine tartrate is indicated for use as monotherapy only. bmi index

A-S Medication Solutions

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] nausea` `[4] diarrhoea` `[5] pain` `[6] dyspnoea` `[7] headache` `[8] dizziness` `[9] off label use` `[10] fall`

5 years ago

ROUND YELLOW K 77

5 years ago

K 77 ROUND YELLOW

HOW SUPPLIED: Product: 50090-0715 NDC: 50090-0715-0 30 TABLET in a BOTTLE NDC: 50090-0715-1 60 TABLET in a BOTTLE NDC: 50090-0715-2 90 TABLET in a BOTTLE NDC: 50090-0715-6 28 TABLET in a BOTTLE NDC: 50090-0715-9 112 TABLET in a BOTTLE NDC: 50090-0715-7 84 TABLET in a BOTTLE

More pills like ROUND K 77

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

phendimetrazine tartrate 35 MG Oral Tablet

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] nausea [4] diarrhoea [5] pain [6] dyspnoea [7] headache [8] dizziness [9] off label use [10] fall

ROUND YELLOW K 77

K 77 ROUND YELLOW

More pills like ROUND K 77

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] nausea` `[4] diarrhoea` `[5] pain` `[6] dyspnoea` `[7] headache` `[8] dizziness` `[9] off label use` `[10] fall`